Search
Check Out Our Sponsors
Latest topics
Topical diazoxide for the treatment of pattern hair loss (and Icariin)
2 posters
Page 1 of 1
Topical diazoxide for the treatment of pattern hair loss (and Icariin)
Diazoxide is a nondiuretic benzothiazide. This potent and rarely anti-hypertensive agent has diverse pharmacologic effects including:
Hypertrichosis (hair growth).
Hyperglycemia associated with suppression of insulin release, which is why it is used to treat idiopathic hypoglycemia of infancy.
Elevation of serum levels of androgens.
Taking advantage of the hypertrichotic side effects of diazoxide, several authors have examined the effect of topical application of the drug on hair re-growth in androgenetic alopecia. A topical formulation of diazoxide was reported in 1989 to show efficacy in male pattern baldness. Nineteen men with "early to midstage" androgenetic alopecia were treated with 3% diazoxide solution twice daily for 2 to 11 months. Reports indicate that four men had a dense growth of new hair, seven had moderate growth by way of some new terminal hairs, one had vellus hair growth, and seven had no re-growth at all. Local irritation occurred in one patient.
The potential mechanism of action of diazoxide in hair growth may be through inhibition of phosphodiesterase. Phosphodiesterase (PDE) is an enzyme that catalyzes the hydrolysis of phosphodiester bonds. PDEs are responsible for the degradation of the cyclic nucleotides cAMP and cGMP. They are therefore important regulators of signal transduction mediated by these molecules. In all probability, dihydrotestosterone hinders energy production by keeping phosphodiesterase relatively inactive and by suppressing various protein (enzyme) synthetases. A relatively high concentration of cAMP may cause premature termination of the growing stages of hair follicles. Repetition of such processes over several years presumably transforms terminal follicles to vellus – type follicles and ultimately causes baldness. However, this theory on the metamorphosis of terminal hair to vellus hair is not proven as yet.
Research studies provide correlative evidence that the opening of potassium channels is an important regulatory mechanism for hair growth. Diazoxide has also been shown, like Minoxidil, to be a potassium channel opener. Therefore oral diazoxide can induce hypertrichosis in a distribution similar to that caused by oral minoxidil but with far less frequency.
A substance found in horny goat weed herb, called icariin, has been shown to inhibit phosphodiesterase type 5 activity.
Hypertrichosis (hair growth).
Hyperglycemia associated with suppression of insulin release, which is why it is used to treat idiopathic hypoglycemia of infancy.
Elevation of serum levels of androgens.
Taking advantage of the hypertrichotic side effects of diazoxide, several authors have examined the effect of topical application of the drug on hair re-growth in androgenetic alopecia. A topical formulation of diazoxide was reported in 1989 to show efficacy in male pattern baldness. Nineteen men with "early to midstage" androgenetic alopecia were treated with 3% diazoxide solution twice daily for 2 to 11 months. Reports indicate that four men had a dense growth of new hair, seven had moderate growth by way of some new terminal hairs, one had vellus hair growth, and seven had no re-growth at all. Local irritation occurred in one patient.
The potential mechanism of action of diazoxide in hair growth may be through inhibition of phosphodiesterase. Phosphodiesterase (PDE) is an enzyme that catalyzes the hydrolysis of phosphodiester bonds. PDEs are responsible for the degradation of the cyclic nucleotides cAMP and cGMP. They are therefore important regulators of signal transduction mediated by these molecules. In all probability, dihydrotestosterone hinders energy production by keeping phosphodiesterase relatively inactive and by suppressing various protein (enzyme) synthetases. A relatively high concentration of cAMP may cause premature termination of the growing stages of hair follicles. Repetition of such processes over several years presumably transforms terminal follicles to vellus – type follicles and ultimately causes baldness. However, this theory on the metamorphosis of terminal hair to vellus hair is not proven as yet.
Research studies provide correlative evidence that the opening of potassium channels is an important regulatory mechanism for hair growth. Diazoxide has also been shown, like Minoxidil, to be a potassium channel opener. Therefore oral diazoxide can induce hypertrichosis in a distribution similar to that caused by oral minoxidil but with far less frequency.
A substance found in horny goat weed herb, called icariin, has been shown to inhibit phosphodiesterase type 5 activity.
LittleFighter- Posts : 1114
Join date : 2009-07-07
Re: Topical diazoxide for the treatment of pattern hair loss (and Icariin)
Did I misinterpret something or does the text say that:
1. Diazoxide inhibits PDE?
2. Diazoxide causes hyperglycemia and elevates serum androgens?
3. DHT also keeps PDE relatively inactive?
4. Inhibition of PDE leads to accumulation or high concentration of cAMP?
5. High concentrations of cAmp causes premature termination of anagen of hair follicles?
Now, form this, I would conclude that diazoxide is a good scalp hair inhibitor.
1. Diazoxide inhibits PDE?
2. Diazoxide causes hyperglycemia and elevates serum androgens?
3. DHT also keeps PDE relatively inactive?
4. Inhibition of PDE leads to accumulation or high concentration of cAMP?
5. High concentrations of cAmp causes premature termination of anagen of hair follicles?
Now, form this, I would conclude that diazoxide is a good scalp hair inhibitor.
ppm- Posts : 164
Join date : 2009-07-24
Similar topics
» Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss
» Maintenance of optimised hair growth from viable terminal scalp hair follicles at baseline with oral finasteride in male pattern hair loss and first evidence of a "drug dependency" and a post-finasteride "rebound effect".
» primrose + fish oil? "Treatment of male pattern baldness and of unwanted hair growth."
» Why the pattern if hair loss is caused by something other than DHT?
» how many of you have thinning eyebrows as well as pattern hair loss?
» Maintenance of optimised hair growth from viable terminal scalp hair follicles at baseline with oral finasteride in male pattern hair loss and first evidence of a "drug dependency" and a post-finasteride "rebound effect".
» primrose + fish oil? "Treatment of male pattern baldness and of unwanted hair growth."
» Why the pattern if hair loss is caused by something other than DHT?
» how many of you have thinning eyebrows as well as pattern hair loss?
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
|
|
Today at 7:01 am by Atlas
» zombie cells
Sat May 11, 2024 6:54 am by CausticSymmetry
» Sandalore - could it be a game changer?
Wed May 08, 2024 9:45 pm by MikeGore
» *The first scientific evidence in 2021 that viruses do not exist*
Tue May 07, 2024 4:18 am by CausticSymmetry
» China is at it again
Tue May 07, 2024 4:07 am by CausticSymmetry
» Ways to increase adult stem cells
Mon May 06, 2024 5:40 pm by el_llama
» pentadecanoic acid
Sun May 05, 2024 10:56 am by CausticSymmetry
» Exosome Theory and Herpes
Fri May 03, 2024 3:25 am by CausticSymmetry
» Road to recovery - my own log of everything I'm currently trying for HL
Tue Apr 30, 2024 1:55 pm by JtheDreamer